StageZero Life Sciences Ltd (SZLS) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.013x

Based on the latest financial reports, StageZero Life Sciences Ltd (SZLS) has a cash flow conversion efficiency ratio of 0.013x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-145.57K ≈ $-105.30K USD) by net assets (CA$-11.13 Million ≈ $-8.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see StageZero Life Sciences Ltd market capitalisation for the company's overall valuation and market capitalisation.

StageZero Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (1998–2022)

This chart illustrates how StageZero Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

StageZero Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of StageZero Life Sciences Ltd ranked by their cash flow conversion efficiency. Explore SZLS cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Evogene TA:EVGN	-0.220x
Akshar Spintex Limited NSE:AKSHAR	0.025x
NR 21 S.A. PA:NR21	-0.008x
Minco Capital Corp V:MMM	0.009x
Whitemud Resources Inc V:WMK	0.164x
Raja Ferry Port Public Company Limited BK:RP	0.059x
EPRCOMUNICAZIONE S.P.A. F:J3P	N/A
Transition Metals Corp V:XTM	-0.209x

Annual Cash Flow Conversion Efficiency for StageZero Life Sciences Ltd (1998–2022)

The table below shows the annual cash flow conversion efficiency of StageZero Life Sciences Ltd from 1998 to 2022. View StageZero Life Sciences Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	CA$-7.50 Million ≈ $-5.43 Million	CA$-3.53 Million ≈ $-2.55 Million	0.470x	+114.50%
2021-12-31	CA$2.76 Million ≈ $2.00 Million	CA$-8.95 Million ≈ $-6.48 Million	-3.242x	-230.51%
2020-12-31	CA$-1.23 Million ≈ $-892.28K	CA$-3.06 Million ≈ $-2.22 Million	2.484x	+143.05%
2019-12-31	CA$-4.49 Million ≈ $-3.25 Million	CA$-4.59 Million ≈ $-3.32 Million	1.022x	+50.23%
2018-12-31	CA$-4.84 Million ≈ $-3.50 Million	CA$-3.29 Million ≈ $-2.38 Million	0.680x	-46.33%
2017-12-31	CA$-3.02 Million ≈ $-2.18 Million	CA$-3.82 Million ≈ $-2.77 Million	1.268x	+62.76%
2016-12-31	CA$-4.73 Million ≈ $-3.42 Million	CA$-3.68 Million ≈ $-2.66 Million	0.779x	-20.01%
2015-12-31	CA$-1.77 Million ≈ $-1.28 Million	CA$-1.73 Million ≈ $-1.25 Million	0.974x	+236.66%
2014-12-31	CA$2.15 Million ≈ $1.56 Million	CA$-1.54 Million ≈ $-1.11 Million	-0.713x	+71.36%
2013-12-31	CA$1.74 Million ≈ $1.26 Million	CA$-4.34 Million ≈ $-3.14 Million	-2.488x	-210.51%
2012-12-31	CA$5.07 Million ≈ $3.67 Million	CA$-4.06 Million ≈ $-2.94 Million	-0.801x	-109.11%
2011-12-31	CA$-321.56K ≈ $-232.61K	CA$-2.83 Million ≈ $-2.05 Million	8.800x	+131.32%
2010-12-31	CA$87.69K ≈ $63.43K	CA$-2.46 Million ≈ $-1.78 Million	-28.100x	-1417.74%
2009-12-31	CA$2.49 Million ≈ $1.80 Million	CA$-4.61 Million ≈ $-3.34 Million	-1.851x	+57.36%
2008-12-31	CA$1.73 Million ≈ $1.25 Million	CA$-7.51 Million ≈ $-5.43 Million	-4.342x	-622.04%
2007-12-31	CA$13.81 Million ≈ $9.99 Million	CA$-8.31 Million ≈ $-6.01 Million	-0.601x	-88.69%
2006-12-31	CA$19.54 Million ≈ $14.13 Million	CA$-6.23 Million ≈ $-4.51 Million	-0.319x	-80.16%
2005-12-31	CA$5.93 Million ≈ $4.29 Million	CA$-1.05 Million ≈ $-758.95K	-0.177x	+45.23%
2004-12-31	CA$7.69 Million ≈ $5.56 Million	CA$-2.48 Million ≈ $-1.80 Million	-0.323x	-294.68%
2003-12-31	CA$5.74 Million ≈ $4.15 Million	CA$-469.80K ≈ $-339.85K	-0.082x	+80.16%
2002-12-31	CA$1.71 Million ≈ $1.24 Million	CA$-707.49K ≈ $-511.78K	-0.413x	+9.50%
2001-12-31	CA$2.29 Million ≈ $1.66 Million	CA$-1.04 Million ≈ $-755.27K	-0.456x	+43.12%
2000-12-31	CA$2.32 Million ≈ $1.68 Million	CA$-1.86 Million ≈ $-1.34 Million	-0.801x	+6.73%
1999-12-31	CA$34.76K ≈ $25.15K	CA$-29.87K ≈ $-21.61K	-0.859x	-2739.35%
1998-12-31	CA$165.36K ≈ $119.62K	CA$-5.00K ≈ $-3.62K	-0.030x	--

About StageZero Life Sciences Ltd

TO:SZLS Canada Diagnostics & Research

Market Cap

$3.58 Million

CA$4.94 Million CAD

Market Cap Rank

#29282 Global

#1358 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$0.04

All Time High

CA$4.16